2024-10-18 - Analysis Report
## Thermo Fisher Scientific Inc. (TMO) Stock Analysis Report

**Company Overview:** Thermo Fisher Scientific Inc. is a global leader in providing analytical instruments, life science products, and laboratory services. 

**1. Performance Comparison to S&P 500 (VOO):**

* **Cumulative Return (TMO):** 238.0%
* **Cumulative Return (VOO):** 136.93%
* **Return Difference:** 101.07%
* **Relative Divergence:** 46.86% (TMO has outperformed VOO significantly in the past, but currently sits at the 46.86% percentile of its historical performance relative to VOO).

**2. Recent Price Movement:**

* **Closing Price:** $591.55
* **5-Day Moving Average:** $596.96
* **20-Day Moving Average:** $605.68
* **60-Day Moving Average:** $606.91

The stock price is currently below its 5-, 20-, and 60-day moving averages, indicating potential downward pressure.

**3. Technical Indicators:**

* **RSI:** 26.87 (The RSI is below 30, indicating oversold conditions. This suggests a potential rebound in the short term.)
* **PPO:** -0.24 (The PPO is negative, indicating a weakening momentum. However, the recent negative divergence suggests potential for a short-term rebound.)
* **Delta_Previous_Relative_Divergence:** -8.79 (Negative value indicates a short-term downward trend. This aligns with the negative PPO and oversold RSI.)
* **Expected Return:** 13.979739075% (Represents a potential 5-year expected return, exceeding the S&P 500, considering current investment amount.)

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-02 | 4.05 | $10.54 B |
| 2024-05-03 | 3.47 | $10.35 B |
| 2023-11-03 | 4.44 | $10.57 B |
| 2023-08-04 | 3.53 | $10.69 B |
| 2024-08-02 | 3.53 | $10.69 B |

Thermo Fisher Scientific has consistently delivered solid earnings and revenue growth. The most recent earnings report showed strong performance exceeding analysts' expectations. This suggests positive momentum for the company's future prospects.

**5. News and Recent Issues:**

* **Recent Market Outlook for given stock:** Despite the recent downward trend, TMO remains a strong performer in the healthcare sector. Its dominance in the scientific instruments and laboratory services market, coupled with its consistent track record, makes it an attractive long-term investment for many investors.
* **Analyst Opinions and Performance Highlights:** The majority of analysts are bullish on TMO, citing its strong fundamentals, robust growth trajectory, and potential for continued market share expansion. FINBOLD recently reported on TMO's strong earnings performance and highlighted its leading position in the industry.

**6. Overall Analysis:**

Thermo Fisher Scientific Inc. is a well-established company with a strong financial position and a solid track record of delivering consistent growth. While the stock has recently experienced some downward pressure, technical indicators suggest potential for a rebound in the short term. The company's strong earnings performance, positive analyst sentiment, and long-term growth prospects continue to support its attractiveness as a long-term investment. The current oversold condition and positive expected return present an opportunity for investors considering a potential entry point. 

**7. Recommendations:**

* **Long-term Investment:**  TMO is a solid long-term investment, with potential for continued growth and market share expansion.
* **Short-term Opportunity:** The current oversold condition and positive expected return could present an opportunity for short-term gains. 
* **Monitor Technical Indicators:**  It is crucial to monitor technical indicators closely, particularly the RSI and PPO, for signs of a potential shift in momentum.

This analysis provides a comprehensive overview of TMO, but it is crucial to conduct thorough research and consider your own investment goals and risk tolerance before making any investment decisions. 
